1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance
(
- Contribution to journal › Article
- 2018
-
Mark
Somatic late effects in 5-year survivors of neuroblastoma : a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia study
(
- Contribution to journal › Article
- 2015
-
Mark
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis
(
- Contribution to journal › Article
- 2012
-
Mark
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
(
- Contribution to journal › Article
-
Mark
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth
(
- Contribution to journal › Article
- 2009
-
Mark
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo
(
- Contribution to journal › Article
- 2008
-
Mark
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
(
- Contribution to journal › Article
-
Mark
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is'-down-regulated by MYCN
(
- Contribution to journal › Article